AMSP opens COVID-19 vaccines pre-orders for 55 African Union Member States

an operational guide to support all those responsible for planning and implementing the rollout of COVID-19 vaccine to refugees and migrants at national and local levels, 14 March 2022

обновленная версия от 04/10/2021 Информация о введении вакцин

updated version: 04/10/2021 Information about vaccine administration

This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered. This document has been updated: 31 August 202

4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at the lower store levels and immunization service points. However, vaccine shelf life is affected when vaccine is transferred to a different storage temperature. Health workers in charge of managing the storage, transport and administration of the vaccine should be well trained to maintain vaccine quality. Good cold chain planning, strong management of vaccine supply, logistics and distribution, including installation and effective monitoring and evaluation of the performance of the storage equipment and infrastructure, are also necessary

Press Release 14 June 2021

Information about vaccine administration

L’objectif du présent Mode opératoire normalisé (MON) est de décrire le processus détaillé de gestion des flacons de vaccin anti-COVID-19 et des déchets associés jetés au terme d���activités de vaccination contre la COVID-19. Le mode opératoire normalisé fournit des instructions claires sur le traitement approprié et l’élimination en toute sécurité de ces déchets afin de minimiser tout risque sanitaire associé en tenant compte du contexte local